# Thomas Dove

En popüler podcast bölümleri
Güncellenmiş:

Why Diversity of Thinking Builds Better Oncology Teams with Yariv Hefez

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Yariv Hefez, Senior Vice President and Head of Global Business Franchise Oncology at Merck Group. Yariv built his career across three distinct fields: law, entrepreneurship and pharmaceutical leadership. He has built bus…

Situational Leadership and Team DNA in Life Sciences Operations with Tom Hochuli

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Tom Hochuli, Chief Executive Officer (CEO) and Board Member at Millrock Technology. Tom Hochuli is a military-trained operator whose career spans Army platoon leadership to CEO roles in life sciences manufacturing, inclu…

Bridging Commercial & Operations in CDMO with Michael Stanek

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Michael Stanek, former Vice President (VP) and General Manager (GM) API Global at Thermo Fisher Scientific. With more than 25 years in the contract development and manufacturing (CDMO) sector, Michael has led turnaround…

Courage, Reinvention & Talent Development in Life Sciences with Michaela Griggs

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Michaela Griggs, Chief Executive Officer (CEO) at Ansella Therapeutics. Michaela Griggs is a turnaround CEO and board director whose career has encompassed global commercial leadership at Bayer and Allergan, CEO position…

Building Win-Win Deals in Generics With Anish Mehta

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Anish Mehta, Chief Executive Officer (CEO) of Synthon. Anish Mehta is a global pharmaceutical CEO whose career spans engineering, strategy consulting, commercial leadership, mergers and acquisitions (M&A), and private e…

What You Know, Who You Know and How You're Known with John Tomtishen

In this episode of the Active Ingredients podcast, host Thomas Dove interviews John Tomtishen, Cell and Gene Therapy Executive Leader and Recognised CMC Expert John Tomtishen has spent over a decade in cell and gene therapy, helping deliver the first approved CAR-T therapy at Novartis, building the…

Behind Glass: What Cdmo Leadership Really Demands With Joerg Ahlgrimm

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Joerg Ahlgrimm, Chief Executive Officer (CEO) of SK Pharmteco. Joerg Ahlgrimm has led global manufacturing networks at Baxter and Lonza, founded the gene therapy contract development and manufacturing organisation (CDMO)…

The Eustace Diamonds Chapter XXV - Mr - Dove's Opinion

In which the astute Mr. Thomas Dove, a counsel of formidable legal learning and unyielding certainty, delivers a detailed opinion on the complex and nuanced matter of the Eustace diamonds, elucidating the distinctions between heirlooms, paraphernalia, and personal property with precise reference to…

Leading With Gemba And Purpose In Manufacturing With Craig Sommerville

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Craig Sommerville, Independent Consultant in Supply Chain Strategy and Transformation at Springbank Consulting Ltd. Craig Sommerville built his career in large pharma and CDMO manufacturing, spending over 25 years at GS…

Defining The Problem Before Acting In Pharma Leadership With Dr R Ananthanarayanan

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Dr R Ananthanarayanan, global biopharma and healthcare executive and former Chief Executive Officer (CEO) of Teva's active pharmaceutical ingredients business. Ananth, as he is known in the industry, has more than four …